OVID Ovid Therapeutics Inc.
Price Chart
Executive Summary
Ovid Therapeutics appointed Dr. Anna Greka, a Harvard Medical School professor and Broad Institute executive, as a Class III director effective June 15, 2026, expanding the board to seven members. This is a routine board appointment with no material financial impact.
Actionable Insight
Routine board appointment with no immediate trading implications. Monitor for any future scientific or strategic developments tied to Dr. Greka's expertise in kidney disease and biotech venture advisory.
Key Facts
- Board expanded from six to seven directors effective June 15, 2026
- Dr. Anna Greka appointed as Class III director with term expiring at 2029 annual meeting
- Dr. Greka also appointed to Compensation Committee and Science and Technology Committee
- Dr. Greka is Professor of Medicine at Harvard Medical School and holds leadership roles at Broad Institute
- Compensation follows standard non-employee director policy; standard indemnification agreement entered
Financial Impact
No financial figures disclosed; compensation is standard non-employee director policy
Risk Factors
- No material risks identified from this filing
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-040038 |
| Document: 0001628280-26-040038-index-headers.html | 0001628280-26-040038 |
| Document: 0001628280-26-040038-index.html | 0001628280-26-040038 |
| Document: 0001628280-26-040038.txt | 0001628280-26-040038 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 3, 2026
11d ago
|
8-K
| $2.39 $2.48 | ▲ +3.77% | ▲ +3.37% | $2.30 (−3.77%) |
|
May 12, 2026
4w ago
|
Press Release
| $2.87 $2.80 | ▼ −2.44% | ▼ −3.01% | $2.30 (−19.86%) |
|
Apr 27, 2026
7w ago
|
EFFECT
| $2.69 $2.70 | ▲ +0.37% | ▲ +0.86% | $2.30 (−14.50%) |
|
Apr 21, 2026
7w ago
|
S-3
| $2.66 $2.68 | ▲ +0.75% | ▲ +1.15% | $2.30 (−13.53%) |
|
Apr 20, 2026
7w ago
|
8-K
| $2.89 $2.85 | ▼ −1.38% | ▼ −0.73% | $2.30 (−20.42%) |
|
Mar 18, 2026
12w ago
|
8-K
| $2.30 $2.30 | · 0.00% | ▲ +0.27% | $2.30 (−0.00%) |
|
Mar 18, 2026
12w ago
|
Press Release
| $2.30 $2.30 | · 0.00% | ▲ +0.27% | $2.30 (−0.00%) |
|
Mar 18, 2026
12w ago
|
Press Release
| $2.30 $2.30 | · 0.00% | ▲ +0.27% | $2.30 (−0.00%) |
|
Feb 23, 2026
16w ago
|
Insider Cluster
| $1.45 $1.51 | ▲ +4.14% | ▲ +3.40% | $2.30 (+58.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access